World’s Smallest & Lightest Artificial Heart Assist Device

Witness the world’s smallest and lightest artificial heart assist device in action—spanning from China to Indonesia, Thailand, and beyond.

This breakthrough in mechanical circulatory support represents a new generation of LVAD technology, engineered to deliver powerful cardiac assistance in a remarkably compact and lightweight form. Designed to support patients with advanced heart failure, it offers the potential for greater mobility, improved comfort, and enhanced quality of life.

From early clinical adoption in China to real-world implementation across Southeast Asia and on the global stage, this innovation is changing what is possible in heart assist therapy—bringing advanced care closer to patients, wherever they are in the world.

Some Benefits of the World’s Smallest & Lightest Artificial Heart Assist Device

Small-sized and lightweight compared to dominant US-made devices. The diameter is reduced by 40%, and the weight is reduced by 50%.

Low power consumption of up to 33 hours, with long endurance and a 50% reduction in the weight of peripherals.

Fewer infections with extra long durability; both percutaneous cable infection and severe infection have been reported as 0 case in clinical trial.

Better hemocompatibility with faster recovery of patients compared to similar LVADs.

LVAD-Related Training for Doctors

Various trainings, both online and face-to-face, involving over a hundred surgeons and physicians, marking an unprecedented step forward in the Indonesia’s heart care development and promoting a glocal exchange of medical knowledge and surgical expertise.

Watch the video below to see some highlights from the recently conducted training in China, attended by Dr. Lim Chong Hee, who performed the first implantation of a United States–made artificial heart assist device in Asia and is now a founding stakeholder of Indonesia.md, and Dr. Yan Efrata Sembiring, a leading cardiothoracic surgeon from Surabaya.